IL-33, an alarmin of the IL-1 family involved in allergic and non allergic inflammation: focus on the mechanisms of regulation of its activity

C Cayrol - Cells, 2021 - mdpi.com
Interleukin-33 (IL-33) is a member of the interleukin-1 (IL-1) family that is expressed in the
nuclei of endothelial and epithelial cells of barrier tissues, among others. It functions as an …

Left ventricular remodeling after myocardial infarction: from physiopathology to treatment

SA Leancă, D Crișu, AO Petriș, I Afrăsânie, A Genes… - Life, 2022 - mdpi.com
Myocardial infarction (MI) is the leading cause of death and morbidity worldwide, with an
incidence relatively high in developed countries and rapidly growing in developing …

[HTML][HTML] Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective

S Salvioli, MS Basile, L Bencivenga, S Carrino… - Ageing Research …, 2023 - Elsevier
According to the Geroscience concept that organismal aging and age-associated diseases
share the same basic molecular mechanisms, the identification of biomarkers of age that can …

Dual immune regulatory roles of interleukin-33 in pathological conditions

H Guo, EA Bossila, X Ma, C Zhao, Y Zhao - Cells, 2022 - mdpi.com
Interleukin-33 (IL-33), a member of the IL-1 cytokine family and a multifunctional cytokine,
plays critical roles in maintaining host homeostasis and in pathological conditions, such as …

Aptamers targeting cardiac biomarkers as an analytical tool for the diagnostics of cardiovascular diseases: A review

N Komarova, O Panova, A Titov, A Kuznetsov - Biomedicines, 2022 - mdpi.com
The detection of cardiac biomarkers is used for diagnostics, prognostics, and the risk
assessment of cardiovascular diseases. The analysis of cardiac biomarkers is routinely …

Biomarkers associated with cardiovascular disease in COVID-19

CC Kaufmann, A Ahmed, AL Burger, M Muthspiel… - Cells, 2022 - mdpi.com
Coronavirus disease-19 (COVID-19) emerged late December 2019 in the city of Wuhan,
China and has since spread rapidly all over the world causing a global pandemic. While the …

Cardiovascular biomarkers for prediction of in-hospital and 1-year post-discharge mortality in patients with COVID-19 pneumonia

LJ Motloch, P Jirak, D Gareeva, P Davtyan… - Frontiers in …, 2022 - frontiersin.org
Aims While COVID-19 affects the cardiovascular system, the potential clinical impact of
cardiovascular biomarkers on predicting outcomes in COVID-19 patients is still unknown …

Predictive Value of GDF-15 and sST2 for Pulmonary Hypertension in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Z Lv, G Liang, M Cheng - International Journal of Chronic …, 2023 - Taylor & Francis
Objective To confirm whether growth differentiation factor-15 (GDF-15) and soluble
suppression of tumorigenicity 2 (sST2) are indicators of pulmonary hypertension in acute …

Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential …

M Ozorowski, M Wiciński, Ł Wróbel… - Nutrition & …, 2022 - Springer
Background Vitamin D deficiency is one of the most common health issues in developed
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D3 (25 (OH) …

Clinical Review of Hypertensive Acute Heart Failure

R Lasica, L Djukanovic, J Vukmirovic, M Zdravkovic… - Medicina, 2024 - mdpi.com
Although acute heart failure (AHF) is a common disease associated with significant
symptoms, morbidity and mortality, the diagnosis, risk stratification and treatment of patients …